We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
CTGrade GMP rh EGF
CTGrade GMP rh EGF is a recombinant human protein that is produced from E. coli and is designed to support preclinical and clinical research, as well as commercial applications, and offers:
- High biological activity verified by a relevant bioactivity assay
- Low endotoxin levels
- ≥ 98% purity
- High lot-to-lot consistency
Size: 50 µg, 100 µg, and 1 mg. Custom sizes and packaging available on request.
EGF (epidermal growth factor) binds to the EGF receptor, a protein kinase that initiates the intracellular signaling, and is widely distributed in tissues like the kidney, cerebrum, prostate, and salivary glands.
- Acts as a potent factor in promoting cell division and activating complex downstream signaling cascades
- Stimulates the proliferation, differentiation, and survival of epithelial and epidermal cells
- Activates at least four major downstream signaling pathways, including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLC gamma-PKC, and STAT modules
- Initiates diverse cellular pathways in response to toxic environmental stimuli
For the development of advanced cell therapies, FUJIFILM Irvine Scientific is your one-stop-shop for the high-performing recombinant proteins required for expansion, proliferation, differentiation, and activation of immune and stem cells. Our CTGrade GMP recombinant proteins can be purchased separately or as a bundle with one of our high-performing PRIME-XV or classical media for a cost-effective solution.
The biological activity of CTGrade GMP interleukins and growth factors is standardized, where applicable, to WHO International standards, providing cell and gene therapy developers consistent, lot-to-lot biological activity and performance.
The CTGrade GMP products are manufactured in a facility that does not use or process beta-lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. These products are manufactured, tested, and released in an ISO 9001:2015 certified facility following cGMP practices. USP chapter <1043> for ancillary materials has been considered in the manufacture of these products.
SDS-PAGE Showing Single Prominent Bands at 6.2 kDa and 6.0 kDa
Figure 1. CTGrade GMP rh EGF (1 μg) was resolved with SDS-PAGE under non-reducing (NR) and reducing (R) conditions, visualized by InstantBlue staining showing a single prominent band at 6.2 kDa (NR) and 6.0 kDa (R).
Cell-Based Proliferation Assay
Figure 2. The biological activity of CTGrade GMP rh EGF was determined in a BALC/c 3T3 cell-based proliferation assay.
Technical Specifications
Alternate Names | Urogastrone, URG |
Accession Number | P01133 |
AA Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
Predicted Molecular Mass | Monomer, 6.2 kDa (53 aa) |
Formulation | CTGrade GMP rh EGF is lyophilized from a 0.2 μm filtered solution containing 0.1% trifluoroacetic acid |
Protein Purity | ≥ 98% determined by reducing and non-reducing SDS-PAGE analysis |
Endotoxin | ≤ 0.01 EU/μg using USP <85> / EP 2.6.14 |
Bioactivity | ED50 is determined by the dose-dependent Proliferation of BALB/c 3T3 cells. The ED50 is typically less than 0.1 ng/mL. The international units of CTGrade GMP rh EGF is approximately 1.0 x 103 IU/µg, which is calibrated against recombinant Human Epidermal Growth Factor WHO International Standard (NIBSC code 91/530). |
Quality | Carrier-free and no animal- or human-derived materials were used during manufacturing |